HomeInvestors HealthBristol Myers to report Q4 IPRD/licensing expense of $18M Bristol Myers to report Q4 IPRD/licensing expense of $18M By BOMAR ENT. January 7, 2025 FacebookTwitterPinterestWhatsApp Bristol Myers to report Q4 IPRD/licensing expense of $18M Source link Previous articleTesla Stock Price Levels to Watch After Volatile StretchNext articleInvest Like a Girl: Jump into the Stock Market, Reach Your Money Goals, and Build Wealth latest articles explore more Reading Stock Charts: A Beginner’s Guide to Technical Analysis (The One Hour Expert) Stock Market Today: Stocks Dragged Down by Strong Data Top Accounting Software Features Every Short-Term Rental Investor Needs The Little Book That Still Beats the Market AVITA Medical stock slides 14% on lowered guidance (RCEL:NASDAQ) The Little-Known Stock Behind Thousands of ETFs LEAVE A REPLY Cancel reply Comment: Please enter your comment! Name:* Please enter your name here Email:* You have entered an incorrect email address! Please enter your email address here Website: Save my name, email, and website in this browser for the next time I comment.